Since C9orf72 is an effector of SG formation and elimination (Figure 6), we presume that C9orf72 deficiency promotes pathological SG persistence caused by a gain of toxicity in patients with ALS/FTD, exacerbating the condition of patients. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.